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 • REVIEW
Mitral valve disease is the most common valvular heart disorder, affecting almost 10% of people over 75 years 
of age (1). Mitral regurgitation is the most common dis-
order of the mitral valve and can be divided into primary 
(structural or degenerative abnormality of the mitral valve) 
or secondary (disease of the left ventricle [LV] interfering 
with the function of the mitral valve apparatus) mitral re-
gurgitation (2). Both primary and secondary mitral regur-
gitations are associated with significant morbidity, includ-
ing an increased risk for heart failure and arrhythmia and 
increased mortality (3,4). Mitral stenosis is less common 
than mitral regurgitation, affecting 0.2% of the population 
(1). It is most commonly caused by rheumatic disease, but 
heavy calcification of the mitral annulus with involvement 
of the leaflets can also produce significant stenosis, particu-
larly in the elderly population (5). Options for intervention 
in mitral valve disease have advanced significantly in the 
past decade (2). With the rapid development of percuta-
neous mitral valve therapies, radiologists and cardiologists 
will need to advance their understanding of mitral valve 
anatomy and function to meet the growing clinical need 
for informative periprocedural imaging. The mitral valve 
is a much more complex structure than the aortic valve 
as it cannot be considered in isolation. Rather, it requires 
an understanding of the valve and the subvalvular mitral 
apparatus, as well as their anatomic relationships and role 
in function, all of which vary across mitral valve pathol-
ogy (6). Historically, the role of noninvasive imaging for 
the assessment of the mitral valve has been largely limited 
to the assessment of hemodynamic disturbances through 
the use of echocardiography (7–9). With the introduction 
of percutaneous annuloplasty devices, transcatheter mi-
tral valve (TMV) repair and TMV replacement (TMVR), 
noninvasive imaging is playing an ever-greater role in the 
anatomic and functional evaluation (10–13). Importantly, 
echocardiography is no longer the only test needed for 
mitral evaluation. CT is playing an increasing role in an-
nular assessment, landing zone characterization, defining 
relevant relationships with adjacent structures, and even in 
the adjudication and grading of mitral valvular stenosis 
and regurgitation (14). In this review, we focus on the es-
sential elements and recent advancements of mitral valve 
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assessment in the context of TMV interventions and the com-
plementary roles of echocardiography and multidetector CT.
Essential Anatomy of the Mitral Valve
The mitral valve anatomy has proven to be more challenging 
for evaluation than the aortic annulus. The aortic annulus 
is a vascular structure at the junction of the aorta and the 
LV defined by the crown-shaped insertion of the aortic valve 
cusps. The aortic annulus may be analyzed in an axial oblique 
imaging plane aligned so as to intersect the most basal hinge 
points of these three cusps. The mitral valve apparatus on 
the other hand comprises much more than a simple annular 
plane between the left atrium and LV. Rather, the mitral valve 
apparatus includes a fibrous annulus, chordae, and papillary 
muscles and their attachments, as well as the mitral valve leaf-
lets (6,10,11,15) (Fig 1).
Annulus
The mitral annulus is a nonsymmetric fibrous structure with 
a three-dimensional (3D) saddle-shaped configuration. This 
consists of two horns, or peaks, separated by a nadir located in 
close approximation to the medial and lateral fibrous trigones 
(triangular-shaped fibrous structures at the inflection of the 
mitral annulus). The anterior horn of the mitral annulus pro-
ceeds in an upward fashion to the root of the aorta, where it is 
in fibrous continuity with the aortic valve–a key distinguish-
ing feature of the anatomic LV. This continuity is known as 
the “aortomitral continuity” or the “intervalvular fibrosa.” The 
aortomitral continuity is one of the most readily appreciable 
components of the fibrous endoskeleton of the heart on im-
ages (Fig 1, B and D). Due to its interposition between the 
mitral and aortic valves, it inherently encroaches upon the LV 
outflow tract (LVOT). This relationship is critical for consid-
eration of anatomic suitability for TMVR (examined in more 
detail in the section LVOT Obstruction Assessment). In non-
diseased state, the posterior horn is located at the junction 
of the atrial and ventricular myocardium and it is where the 
posterior mitral valve leaflet inserts (Fig 1, B and D). The 
fibrous trigones represent the anatomic junction between 
the anterior and posterior annulus and define the nadir of the 
saddle-shaped annulus; these are key structures in the assess-
ment of the mitral valve as they can readily and reliably be 
identified on CT scans as focal areas of triangular thickening 
(Fig 1, E).
Leaflets
The mitral valve has two leaflets, the anterior mitral leaflet 
(AML) and the posterior mitral leaflet (PML), also referred 
to as the aortic and mural leaflets. Each leaflet has three scal-
lops: A1–A3 anteriorly and P1–P3 posteriorly (Fig 1, A and 
C). Importantly, the mitral valve leaflets are unequal in size 
and shape. The AML occupies only one-third of the annu-
lar circumference, whereas the PML occupies the remaining 
two-thirds of the circumference and exhibits a narrower ra-
dial length. The coaptation zone, or line, describes a semi-
lunar arc-like configuration, with the leaflets converging at 
the anterolateral and posteromedial commissures (Fig 1, A). 
These commissures lie approximately 5 mm centripetally to 
the annulus itself (2,6,15). It is well established that the scal-
lops of the PML are more pronounced and clearly defined. 
The scallops of the AML are more poorly defined and are 
often unequal in size, with the middle scallop typically the 
largest. Given partial volume averaging and limited temporal 
resolution of CT, the distinct scallops of the mitral valve are 
not as well seen as on echocardiography. Some of this can be 
overcome through the use of minimum intensity projections 
to improve visualization of the thin low-attenuation leaflets 
in the contrast-enhanced cavity. By convention, the AML and 
PML are each subdivided into three equal components: A1, 
A2, A3 and P1, P2, P3 to designate the lateral, middle, and 
medial segments, respectively (Fig 2).
Subvalvular Apparatus
The subvalvular apparatus comprises the papillary muscles and 
chordae tendinae. The papillary muscles are named by conven-
tion based on their location and the commissures they relate 
to. The anterolateral and posteromedial papillary muscles give 
rise to the anterolateral and posteromedial commissures. While 
these are considered as two muscles, in reality each of these are 
themselves comprised of one to three muscular bundles. These 
typically arise from the apical and mid ventricle, extending ba-
sally to give rise to the fibrous string like chords of the chordae 
tendinae. These chords are highly variable in their number and 
configuration and extend down onto the mitral valve leaflets 
themselves both at the leaflet tips and in the mid leaflet body. 
Chordae can be distinguished on the basis of their leaflet in-
sertion, with marginal or primary chords attached to the free 
edge of the leaflets and the basal or secondary chords inserting 
onto the central body of the anterior leaflet and broadly onto 
the posterior leaflet body. Finally, there are third-order chordae 
that are separate from the papillary muscles, instead extending 
directly from the ventricular wall to the base of the annulus 
and mural leaflet of the valve (6,12,15). While seemingly re-
dundant and unnecessarily complex, this relationship between 
the mitral valve leaflets and papillary muscle chordal complex 
Abbreviations
LV= left ventricle, LVOT = LV outflow tract, MAC = mitral an-
nular calcification, TAVR = transcatheter aortic valve replacement, 
TMV = tanscatheter mitral valve, TMVR = TMV replacement, 3D 
= three-dimensional
Summary
Rapid advancements in transcatheter mitral valve procedures have 
driven an increasing demand on noninvasive imaging to help assist in 
evaluation and procedural planning, with echocardiography and CT 
playing complementary roles in preprocedural work-up.
Essentials
 n Evidence supporting transcatheter mitral valve intervention is 
growing.
 n Echocardiography and CT play a complementary role in the 
work-up for transcatheter mitral valve insertion.
 n A saddle-shaped annulus makes measurement challenging; how-
ever, the CT ability for volumetric anatomic review is well suited 
for this.
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is essential as it helps optimize 
functioning of both the mitral 
valve leaflets and the adjacent 
ventricle. Loss of these cords 
leads to loss of normal ventric-
ular torsion, systolic thicken-
ing, and altered LV morphol-
ogy (16,17).
State of Technology 
in TMV Intervention
There remains some ongoing 
debate as to whether mitral 
valve repair or replacement is 
the best strategy; however, cur-
rent guidelines advocate that 
a repaired native mitral valve 
is preferred when possible 
(18,19).
This debate is more pro-
nounced in the minimally in-
vasive arena, where transcath-
eter procedures can tackle the 
issue of mitral regurgitation via 
repair or replacement. Current 
and new techniques for repair 
take different approaches to 
reduce MR: (a) fasten the two 
leaflets of the mitral valve to-
gether as seen with the Mitra-
Clip (Abbott, Abbott Park, Ill) 
system (20); (b) use individu-
ally adjustable clasps to place 
a spacer between the mitral 
valve leaflets as with the PAS-
CAL (Edwards Lifesciences, Ir-
vine, Calif ) TMV repair system 
(21); (c) directly reduce annu-
lar dimensions through the use 
of implanted annular anchors, 
restoring the mitral leaflets to 
a more functional position as 
with the Cardioband (Edwards 
Lifesciences) mitral valve re-
construction system (22); or 
(d) indirectly reduce the annu-
lar dimension via a device in-
serted into the coronary sinus to improve coaptation of the na-
tive mitral leaflets as with the Carillon Mitral Contour System 
(Cardiac Dimensions, Kirkland, Wash) (23). Transcatheter 
repair techniques are more established than are transcatheter 
replacement systems, having been the first to be introduced 
clinically; however, over the past 3 years rapid development 
and introduction of TMVR devices has occurred, with eight 
such devices now under clinical evaluation (Fig 3) (16).
High technical success rates have been reported with 
use of repair strategies, but these are commonly unable to 
Figure 1: Anatomy of the mitral valve as demonstrated at CT. A, B, The mitral valve is closed at end 
systole. C, D, Images show the opened valve at end diastole, with the location of the three scallops of the 
anterior (A1–A3) and posterior (P1–P3) mitral valve leaflet; arrowhead (B, D) highlights the aortomitral 
continuity forming the anterior horn of the annulus remaining fixed in position throughout the cycle. E, Im-
age shows mitral annulus and fibrous trigones (*). F, Minimum intensity projection at end systole highlights 
the complex fan-like radiation of fine tendinae running from the papillary muscles to the mitral leaflets 
(arrowheads).
eliminate mitral regurgitation entirely, with 57% of patients 
undergoing MitraClip and 45% of patients undergoing 
Cardioband procedures having significant residual mitral 
regurgitation at follow-up (22,24). The procedures are also 
somewhat reliant on the native valvular apparatus integrity 
to seat the device. Another limitation of these procedures 
is their inability to treat mitral valve stenosis or mitral bio-
prosthetic valve failure. That being said, repairing the mi-
tral valve offers the benefit of more natural hemodynamic 
environment, no need for anticoagulation, and a favorable 
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tural intervention, and procedural planning. Echocardiogra-
phy, CT, and MRI play a complementary role in this work-up, 
and the strengths of each should be utilized for the maximum 
benefit of the patient.
Quantification of Mitral Regurgitation
Echocardiography is the imaging technique of first choice in the 
evaluation of patients with mitral regurgitation since it provides 
comprehensive information on the regurgitation severity, its un-
derlying mechanism, and the effect of volume overload on the 
cardiac chambers and pulmonary circulation. This information, 
along with clinical symptoms, determines the clinical treatment 
of patients with mitral regurgitation. In routine clinical practice, 
definition of severe mitral regurgitation is largely based on two-
dimensional Doppler echocardiography. Qualitative param-
eters describe the mitral valve morphology and the characteris-
tics of the regurgitant jet. Semiquantitative parameters reflect 
the degree of volume overload, and quantitative parameters 
estimate the effective regurgitant orifice area and regurgitant 
volume. Together with LV and atrial dimensions, these assess-
ments form a multiparametric approach to grade mitral regur-
gitation (Table 1). These parameters are simple to obtain and 
permit an accurate estimate of the severity of the regurgitant 
lesion in the majority of patients (Fig 4). A discussion of the 
strengths and weaknesses of each of these is beyond the scope 
of the current review, but an excellent overview of these can be 
found in the review by Thavendiranathan et al (28).
safety profile (25,26). TMVR, on the other hand, seeks to 
eradicate mitral regurgitation through the percutaneous re-
placement of the regurgitant mitral valve. Valve replacement 
offers the potential, depending on the design of the device, 
to treat a broader spectrum of mitral valvular disease but at 
present represents a much more complicated strategy with 
many anatomic limitations, particularly given the size of the 
valve that needs to be deployed (16).
The mitral valve offers further challenges that are not shared 
with the aortic valve (27). To start, transcatheter aortic valve 
replacement (TAVR) is performed for aortic stenosis and the 
pathophysiology of aortic stenosis is almost uniformly calcific 
aortosclerosis (27). Mitral regurgitation on the other hand results 
from a wide spectrum of pathologic conditions, ranging from re-
gional and global LV dysfunction to degenerative valvular disease. 
In addition, the mitral annulus is a more complex anatomic 
structure with a nonplanar saddle-shaped configuration and ex-
tensive ventricular attachments and relationships. This complex 
anatomy leaves significant technical challenges that will need to be 
answered with numerous repair and replacement devices currently 
being tested taking a number of different approaches.
Imaging Assessment of the Mitral Valve
Imaging assessment of the mitral valve is essential in the work-
up of mitral regurgitation. It is used for the identification of 
mitral regurgitation, quantification of its severity, characteriza-
tion of its underlying cause, assessment of its suitability for struc-
Figure 2: Assessment of mitral valve geometry with CT in a patient with secondary mitral regurgitation. 
From the reconstructed short-axis view of the mitral valve, the orthogonal plane can be set across the me-
dial (A3–P3), central (A2–P2), and lateral (A1–P1) levels of the mitral valve to obtain the length, tenting 
height, and leaflet angles of the anterior and posterior mitral leaflets.
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Figure 3: Examples of percutaneous mitral valve devices currently in use: A, Tiara (Neovasc, Richmond, BC, 
Canada), B, CardiAQ-Edwards Transcatheter Mitral Valve (Edwards Lifesciences, Irvine, Calif), C, Tendyne (Tendyne 
Holdings, Milosevic, Minn), D, Intrepid TMVR (Medtronic, Minneapolis, Minn ), and, E, Cardioband Mitral Valve Recon-
struction System (Edwards Lifesciences).
Regardless of whether the reader performs echocardiography 
himself or herself or not, it is essential to understand the param-
eters and the thresholds used for the diagnosis and grading of 
severe mitral regurgitation, which is a prerequisite for structural 
intervention. The most important of these and their respective 
thresholds for classification of severe mitral regurgitation are an 
effective regurgitant orifice area of 0.4 cm2 or greater, regurgitant 
volume of 60 mL or greater, and regurgitant fraction of 50% or 
greater (7). However, eccentric regurgitant jets and/or multiple 
regurgitant jets can result in underestimation of the effective re-
gurgitant orifice area and regurgitant volume based on two-di-
mensional proximal isovelocity surface area (29). Three-dimen-
sional echocardiography and acquisition of full-volume color 
Doppler data permits a more accurate definition of the anatomic 
regurgitant orifice area (Fig 5). Use of these tools demonstrated 
better agreement for quantification of regurgitant volume with 
cardiac MRI than with two-dimensional echocardiography, with 
the latter tending to significantly underestimate the regurgitant 
volume (30–32).
Accurate measurement of the regurgitant orifice area is an 
important determinant in the estimation of the regurgitant vol-
ume. Where there is discordance between measures of mitral 
regurgitation severity or between symptom severity and mitral re-
gurgitation severity, other cross-sectional techniques may aid in 
adjudication. MRI plays a key role in this regard. MRI can 
quantify mitral regurgitation in one of three ways: (a) Phase 
contrast sequences, which can be used to quantify aortic flow 
volume and cine sequences can quantify LV stroke volume. 
The difference between the aortic forward flow volume and LV 
stroke volume accurately calculates the mitral regurgitant vol-
ume, with a single study suggesting that this technique better 
predicts favorable LV remodeling following surgical interven-
tion than do echocardiographic parameters of mitral regurgita-
tion severity (33). (b) The difference between LV stroke volume 
and right ventricle stroke volume is equal to the regurgitant 
volume; however, this only holds true in the absence of shunts 
or other valvular regurgitation. (c) Direct quantification of the 
mitral regurgitation through the use of a transannular phase 
contrast sequence acquisition. The accuracy of this is signifi-
cantly reduced in the presence of multiple regurgitant jets and 
underestimates regurgitation if the plane of acquisition is not 
truly perpendicular to the regurgitant jet (34).
Multidetector CT can also play a complementary role. As 
CT acquisition for valvular work-up typically involves full 
cycle acquisition, right ventricle and LV stroke volumes can 
be quantified with the regurgitant volume calculated from the 
stroke volume difference, with this correlating well with MRI 
(35). CT anatomic measures can also be used in conjunction 
with hemodynamic measures from transthoracic echocardiog-
raphy to capitalize on the strengths of both. In a recent study 
of 73 patients with severe aortic stenosis and mitral regurgita-
tion undergoing dynamic multidetector prior to TAVR, mea-
surement of the anatomic regurgitant orifice area was feasible. 
By integrating dynamic CT with Doppler echocardiography 
data, the recalculated regurgitant volume reclassified 14% of 
patients from having nonsignificant to having significant mi-
tral regurgitation (Fig 5) (36).
Mechanism of Mitral Regurgitation
As for the quantification of the severity of mitral regurgita-
tion, echocardiography is key to diagnose the mechanism of 
mitral regurgitation. Primary mitral regurgitation is caused by 
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Table 1: Echocardiographic Criteria of Severe Mitral Regurgitation and Technical Advantages and Limitations
Parameter Severe Mitral Regurgitation Advantages Limitations
Qualitative
 Mitral valve morphology Flail leaflet/ruptured papillary 
muscle
Specific for severe mitral  
regurgitation
Other abnormalities are  
nonspecific for severe mitral 
regurgitation
 Color flow mitral  
regurgitation jet
Large central jet or eccentric jet 
adhering, swirling, and reaching 
the posterior wall of the left 
atrium (coanda effect)
Simple, evaluates spatial orientation  
of the regurgitant jet and is good  
for screening
Inaccurate, particularly in eccen-
tric regurgitant  
jets with coanda effect
 Flow convergence zone Large Simple, flow convergence at  
50 cm/sec indicates significant 
mitral regurgitation
Shape affected by aliasing velocity, 
noncircular regurgitant orifice, 
systolic changes in  
regurgitant flow
 Continuous wave Doppler  
  signal of the mitral  
  regurgitation jet
Dense/triangular Simple Difficult to obtain in eccentric 
regurgitant jets
Semiquantitative
 Vena contracta width (mm) 7 (. 8 for biplane view) Simple, relatively independent of 
hemodynamic factors, not affected 
by other valve leaks, can be used in 
eccentric jets
Not valid for multiple jets
 Mitral inflow E-wave dominant ( 1.2 m/sec) Simple, specific for severe mitral 
regurgitation
Affected by left atrium pressure 
and atrial fibrillation
 Pulmonary vein flow Systolic flow reversal (more 
specific if  
. 1 pulmonary vein)
Simple Affected by left atrium pressure 
and atrial fibrillation and left 
ventricle relaxation
 VTI mitral/VTI aortic .1.4 Simple Affected by left atrium pres-
sure and atrial fibrillation, left 
ventricle relaxation and aortic 
pressures
Quantitative, primary
 EROA (mm2) 40 Not affected by etiology of mitral re-
gurgitation, can be used in eccentric 
jets, quantitative estimates of lesion 
severity
PISA shape affected by aliasing 
velocity, noncircular regurgi-
tant orifice, systolic changes in 
regurgitant flow
 Regurgitant volume (mL) 60 Errors in PISA measurements are 
squared
 Regurgitant fraction (%) 50 Not valid in multiple jets
Source.—Reference 7.
Note.—EROA = effective regurgitant orifice area, PISA = proximal isovelocity surface area, VTI = velocity time integral.
an anatomic abnormality or direct damage of the mitral leaf-
lets, chordae, annulus, and papillary muscles. Secondary mi-
tral regurgitation is caused by regional or global dysfunction 
and/or dilatation of the LV, causing tethering and restriction of 
the mitral leaflets and coaptation failure (Fig 6). Three-dimen-
sional echocardiography provides en face views of the mitral 
valve resembling the surgical view and facilitates the commu-
nication between imagers, cardiac surgeons, and interventional 
cardiologists. In primary mitral regurgitation, 3D echocar-
diography permits accurate characterization and localization 
of the prolapsing scallops and has important implications in 
the evaluation of surgical and transcatheter ability to repair the 
mitral valve (11). The agreement between surgical exploration 
of the mitral valve and 3D transesophageal echocardiography 
is superior to two-dimensional transesophageal echocardiog-
raphy, particularly in patients with complex lesions involving 
multiple mitral scallops, the anterior mitral leaflet, or the com-
missures (76% vs 47%, respectively) (37). In those who cannot 
undergo transoesophageal echocardiography, MRI has been 
demonstrated to have a high accuracy for the detection and 
localization of degenerative mitral valve disease (38). MRI can 
also provide useful information on the underlying etiology of 
functional mitral regurgitation, which can aid in guiding man-
agement strategies (34).
In secondary mitral regurgitation, several parameters of mi-
tral valve and LV remodeling have been associated with high 
rates of mitral regurgitation recurrence after surgical repair (39). 
These measures include (a) mitral valve remodeling—coapta-
tion distance or tenting height greater than 10 mm, tenting 
area greater than 2.5–3 cm2, posteromedial regurgitant jets, and 
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with echocardiographic annulus sizing (40). Building on prior 
experience in aortic intervention, CT has been used in all stud-
ies to date in assessing patients for TMVR (41–44). Although 
CT lacks the capacity to provide hemodynamic information 
for TMVR, it provides highly reproducible evaluation of the 
3D geometry of the mitral valve annulus. CT is also sensitive 
for the detection of annular calcification (45).
CT performed for mitral valve and annulus assessment re-
quires electrocardiogram (ECG) synchronized acquisition (as 
per Table E1 [online]), coverage limited to the heart, coverage 
of the entire cardiac cycle with no dose modulation, contrast-
enhanced scanning triggered from the LV (rather than the aorta 
as typically used in TAVR preassessment), a prolonged injection 
to ensure that there is adequate contrast opacification of the 
right heart so as to allow assessment of the interatrial septum if a 
postero-lateral angle greater than 45° (both indicating significant 
restriction of the posterior mitral leaflet); (b) local LV remodel-
ing—interpapillary muscle distance greater than 20 mm, poste-
rior papillary-fibrosa distance greater than 40 mm, and lateral 
wall motion abnormalities; and (c) global LV remodeling—end 
diastolic diameter greater than 65 mm, end systolic diameter 
greater than 51 mm, systolic sphericity index greater than 0.7. 
These parameters can all be measured at echocardiography, CT, 
and MRI (12,13).
Annular Sizing
CT affords the opportunity for true isometric volumetric 3D 
imaging of the LV, left atrium, and the mitral valve and subval-
vular apparatus. CT is established in the routine work-up for 
TAVR, with superior clinical outcomes with CT sizing than 
Figure 4: Assessment of mitral regurgitation with echocardiography. A, Four-chamber transthoracic echocardiog-
raphy image in a 63-year-old man with severe mitral regurgitation caused by prolapse of the posterior mitral leaflet 
(arrow) leading to an eccentric regurgitant jet toward the interatrial septum on, B, color flow Doppler scan. On, C, 
continuous wave Doppler, the spectral Doppler signal is dense and triangular and on, D, pulsed wave Doppler, note the 
prominent early diastolic (E) wave over the late diastolic (A) wave on transmitral flow and, E, the systolic flow reversal of 
the pulmonary vein flow (arrow) followed by the diastolic flow (D).
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[contrast material and saline]) (46). Tube voltage and tube cur-
rent should be adapted to body habitus as per routine cardiac 
CT protocols (47). A complimentary nongated low-dose chest 
transseptal approach is being considered (typically achieved with 
a single breath hold following injection of 80–110 mL of intra-
venous contrast media at 4–5 mL/sec and a biphasic injection 
Figure 5: Quantification of mitral regurgitant volume with three-dimensional (3D) imaging techniques in an 87-year-old 
patient with moderate mitral regurgitation due to lack of medial coaptation (A3–P3, arrow in A, top left image). A, On 
color Doppler 3D transesophageal echocardiograms, the 3D full-volume data are presented in multiplanar reformation 
planes oriented across the vena contracta of the regurgitant jet. Arrow = the regurgitant orifice area. B, On multidetector 
row CT scans, the multiplanar reformation planes are aligned across the mitral leaflet coaptation line. Note the orifice 
area (red dotted circle) located at the same level (A3–P3). AML = anterior mitral leaflet, Ao = aortic valve, PML = posterior 
mitral leaflet.
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for transcatheter interventions and showed strong correlation (r 
= 0.69 and r = 0.71; P ,. 0001) and no systematic bias (0.77 
mm 6 3.8 [95% confidence interval: 26.7 mm, 8.2 mm] and 
21.5 mm 6 3.1 [95% confidence interval: 24.6 mm; 7.6 mm]) 
between annular measurements obtained by using 3D TEE and 
those obtained by using CT (48). Given the high temporal reso-
lution of TEE, it can provide important insight into mitral an-
nular dynamism and function. Normal dynamics of the mitral 
annulus are characterized by early systolic contraction and more 
pronounced saddle shape, both of which contribute to leaflet 
coaptation. In primary mitral regurgitation due to myxomatous 
valve disease, early contraction is reduced, the intercommisural 
diameter increases, and the saddle shape becomes flatter leading 
to mitral incompetence. In secondary mitral regurgitation, the 
mitral annulus is significantly less dynamic (49,50). The presence 
of mitral annulus calcification also leads to loss of annular contrac-
tion and loss of early systolic folding along the intercommissural 
diameter (Fig 9) (51).
Landing Zone Characterization
CT plays an important role in defining the landing zone for 
TMV procedures. CT can provide detailed and clear defini-
tion of the extent and severity of annular calcium, which can 
help determine device suitability (Fig 9). Exuberant mitral 
CT can be considered to count 
rib spaces if ECG-gated acquisi-
tion is limited to the heart and 
a transapical approach is to be 
used (see section Apex Localiza-
tion and Septal Puncture).
With CT, assessment of the 
mitral valve annulus can either 
be performed by using a true 
saddle-shaped area and perim-
eter or by utilizing a standard-
ized exclusion of the anterior 
horn. Exclusion of the anterior 
horn allows assessment by us-
ing the “D-shaped” concept of 
the mitral annulus, with trun-
cation of the anterior horn at 
the level of the fibrous trigones 
(45). Both can be achieved by 
stepwise placement of seeding 
points at regular intervals along 
the mitral annulus. This creates 
a 3D model of the mitral an-
nulus from which measurement 
of the annulus area, perimeter, 
and septal-lateral and intercom-
misural distance can be per-
formed. Identification of the 
trigones then allows truncation 
of the anterior horn at the level 
of the fibrous trigones creating 
the trigone-to-trigone distance 
(Fig 7). While highly reproduc-
ible, such an approach requires specialized software. An alternate 
approach is a manual technique following a similar technique 
to that used for obtaining the aortic valve annular plane. This 
involves sequential identification of the two fibrous trigones fol-
lowed by the free edge annular ring insertion point (Fig 8) (47).
A number of parameters are integrated into annular sizing 
reports and help inform device selection. These include the 
projected two-dimensional area, perimeter, intercommissural, 
septal-lateral, and intertrigonal distances. The relevance of each 
of these annular measurements varies across device platforms. 
The Tiara device (Neovasc) with its D-shaped configuration 
is highly reliant on the intercommissural distance, as well as 
the projected annular perimeter. The CardiAQ-Edwards TMV 
(Edwards Lifesciences) is sized based on the largest annular di-
ameter (16). Given the early stage in the maturation process of 
TMVR, ongoing investigation is needed to better define the 
sizing requirements needed for these various devices as was the 
case for TAVR devices.
While CT currently holds hegemony in annular assessment 
prior to the procedure, 3D transesophageal echocardiography 
(TEE) sizing of the mitral annulus in the context of TMVR has 
shown good intraobserver and interobserver reproducibility and 
correlation with CT. Mak and colleagues performed an analysis 
of 41 subjects with mitral regurgitation who were being evaluated 
Figure 6: Mitral regurgitation mechanism. A, Two-dimensional transesophageal echocardiography; 
example of primary mitral regurgitation caused by prolapse of the posterior mitral leaflet (arrow). B, On 
three-dimensional transesophageal echocardiogram, the en face view of the mitral valve permits exact 
location and extent of the prolapsing scallop (central scallop P2, arrow). C, Example of secondary mitral 
regurgitation caused by dilatation of the left ventricle (arrows) and subsequent tethering of the leaflets. D, 
The en face view of the mitral valve on three-dimensional transesophageal echocardiogram shows lack of 
coaptation between the anterior and posterior leaflets and the central level (arrows). Ao = aortic valve.
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tissue characterization is a known weakness of echocardiogra-
phy (5,51). The significance of MAC varies by the intended 
approach of intervention. Extensive MAC involving at least 
75% of the circumference of all four quadrants of the annulus 
is a prerequisite for the implantation of aortic transcatheter 
annular calcification (MAC) poses an issue for CT regarding 
segmentation of the annulus. In the case of MAC, correct 
definition of the boundary of the blood pool and calcified 
annular segments can be very difficult. However, MAC also 
poses issues for transesophageal echocardiography because 
Figure 7: D-shaped mitral annular segmentation and measurements. Three-dimensional segmentation is 
performed by manually placing seeding points along the annulus as it is rotated in 22° increments around 
the, A, long-axis plane and by cross-referencing with the corresponding, B, short-axis images. The resul-
tant saddle-shaped mitral annulus contour is composed of the anterior (pink contour) and posterior (red 
contour) horns demarcated by the fibrous trigones (green = medial; blue = lateral, filled circles) as shown 
in C and D. For transcatheter mitral valve planning, the D-shaped annulus, formed by truncation of the an-
terior horn, is used to determine the two-dimensionally projected annular perimeter and area, as well as 
intercommissural (IC), septal-lateral (SL), and trigone-trigone (T T) distances as shown in E.
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clinical feasibility of TMVR valves currently in production. 
Importantly, MAC is a heterogeneous process, with calcium 
varying not only in distribution but in density. Some calci-
fications are extremely dense and rock-like, while a caseous 
heart valves to treat mitral stenosis to provide sufficient pur-
chase for these devices as they anchor themselves based on ra-
dial force and friction (Fig 10) (52). Conversely, severe MAC 
has been a contraindication in studies to date examining the 
Figure 8: Manual technique for obtaining a planar view through the mitral annulus from which the annular area, 
trigone-trigone, and septal-lateral distances can be obtained. After approximately centering the cursor over the mitral 
valve (A–C), an approximate mitral planar view is obtained by aligning the image to the atrioventricular groove (E–G). 
The left fibrous trigone is identified by panning the short-axis oblique view through the upper ventricle (E–G) until the 
well-defined triangle of the trigone comes into view (H, arrowhead). The image should then be centered on the left 
trigone and the vertical axis rotated so that it aligns with the approximate location of the right trigone (G). The right 
fibrous trigone is then obtained by rotating the vertical axis (I–K) until the second well-defined triangular trigone comes 
into view (L, arrowhead). Finally, the free edge of the annulus (dashed yellow line) is obtained by rotating the horizontal 
axis (M–O) until its insertion in the ventricle (P). From this segmentation, the annular area and perimeter (Q) and trigone-
trigone, septal-lateral, and intercommisural distances can be measured (R). Curved arrows indicate rotating the image 
and straight arrows indicate moving the plane without altering its angulation. The right-hand images (D, H, L, P) are the 
approximate appearance the annulus should assume at each step of the process. T T = trigone-trigone, SI = septal-lateral, 
and IC = intercommisural.
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segmentation that is highly reproducible rather than focus-
ing on what is anatomically correct. Clearly defined meth-
odology to ensure consistent and reproducible segmentation 
of MAC will afford the opportunity to correlate these mea-
surements with downstream procedural outcomes and gen-
erate the data necessary to provide more robust guidance in 
this challenging area. If segmentation remains nonstandard-
ized, then it will be impossible to understand how underly-
ing anatomy impacts device expansion, sealing, and eventu-
ally clinical outcomes. As such, the authors advocate that 
the annulus is defined as a harmonious, smoothly margin-
ated structure. In essence, this approach ignores protruding 
pattern is also quite common. The impact on device counter 
bearing is very much dependent on the type and density of 
MAC. Unfortunately, the present classification of MAC is 
qualitative, and there is little evidence to allow estimation 
of the potential impact this may have on device deployment, 
positioning, and expansion.
Currently an evidence-based approach on how to handle 
this calcification, whether to partially include irregularities 
and/or nodules in the annular area or to exclude it entirely 
is not available. Given this limitation both in CT and trans-
esophageal echocardiography, it may be more appropri-
ate to focus on defining a clear process for mitral annular 
Figure 9: Mitral annulus calcification. A, On two-dimensional echocardiogram, calcifications of the mitral annulus, 
extending to the anterior mitral leaflet, are shown (arrowheads). B, On three-dimensional echocardiogram, the software 
provides different color shades to indicate thickness of the mitral valve most probably caused by calcification. In this 
example, the calcifications affect the most lateral levels of the anterior and posterior mitral annulus (arrowheads). C, On 
multidetector row CT scan, the calcifications are clearly visualized on the same locations as on echocardiogram involv-
ing both the annulus but extending to the left fibrous trigone, anterior mitral leaflet, and, to a lesser degree, the posterior 
leaflet (arrowheads).
Figure 10: Valve in mitral annular calcification work-up. A, Severe mitral annulus calcification involving more than 
75% of the annulus circumference, thereby providing enough coverage to provide anchorage for insertion of an 
aortic transcatheter heart valve. B and C, Images demonstrate a satisfactory neo-left ventricular outflow tract (LVOT) 
following the insertion of a simulated 26-mm valve. D–F, Postprocedural CT scans show close agreement with the 
preprocedural simulation, although the neo-LVOT is even more spacious due to an unanticipated inferolateral canter 
to the inserted valve.
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in a coaxial fashion will also greatly impact the postimplant 
LVOT space. In addition, LVOT obstruction can be dy-
namic, mainly due to systolic anterior motion of the anterior 
mitral valve leaflet. Importantly, anatomic assessment with 
CT, including simulation of device implantation, is unable to 
confidently predict what will happen with the anterior mitral 
valve leaflet following TMVR (54,55).
CT can help discriminate the risk of postimplant LVOT 
obstruction. The LVOT remodels following valve deployment 
by undergoing elongation, with the anatomy defined by the de-
ployed valve/leaflet and the ventricular septum. Given the ana-
tomic remodeling of the LVOT, it seems more appropriate to 
provide a new designation for this anatomic compartment; we 
refer to this space as the neo-LVOT. This neo-LVOT is defined 
by drawing a center line through the middle of the residual space 
between the septum and simulated implanted transcatheter de-
vice. The evaluation should then evaluate the residual space de-
fined in a perpendicular fashion to the centerline of the LVOT. 
The neo-LVOT is then determined at the site of the greatest 
encroachment and narrowing. The lower bound of neo-LVOT 
narrowing that will allow for acceptable postimplant gradients 
is not well established. As such, the field has relied on evidence 
from hypertrophic cardiomyopathy based on which a conserva-
tive threshold of 1.5 cm2 has been adopted for consideration of 
being at risk for postprocedural LVOT obstruction (56). In the 
early experience with TMVR, end systolic imaging has been fa-
vored for the evaluation of the neo-LVOT as it yields the most 
conservative data (57) and thus allows for thoughtful discussion 
nodules of calcification during segmentation, thus avoiding 
an individualized and nonstandardized segmentation ap-
proach to such variant anatomy (Fig 10).
CT also plays an important role in defining other landing 
zone features that are relevant to determine the likelihood of 
device capture and sealing. CT can depict and accurately size 
the posterior shelf that commonly develops in the setting of 
functional mitral regurgitation, particularly in the setting of 
prior infarction (46,48). This posterior shelf is needed to assist 
with the capture of some of the self-expanding devices rely-
ing on a persisting posterior shelf throughout the cardiac cycle 
(10,46). Features like mitral annular disjunction (whereby the 
mitral annulus becomes separated from the atrioventricular 
junction) and mitral valve tenting, traditionally evaluated with 
echocardiography, can also be identified and characterized with 
increasing accuracy and detail.
LVOT Obstruction Assessment
LVOT obstruction during transcatheter mitral intervention in 
the treatment of native mitral valves, valve in ring, and valve 
in valve is a feared and potentially catastrophic complication 
(52,53). The mechanisms of obstruction are broad and com-
plex and only modestly understood. Patient-specific variables 
such as ventricular size, septal thickness, anterior mitral valve 
leaflet length, change in ejection fraction, and volume status 
all play a role as do structural and design characteristics of the 
implanted device. Procedural factors such as device canting or 
tilting toward the LVOT and inability to deploy the valve 
Figure 11: Prediction of risk of left ventricular obstruction following mitral valve insertion. A, Three-chamber, B, two-
chamber, and, C, en face views of the mitral annulus (red line) with a three-dimensional simulation of the intended 
device to be inserted (green meshwork) seated within the annulus at end systole. A centerline is prescribed through the 
neo-left ventricular outflow tract (orange line in A), and, D, at the point where the simulated valve comes closest to the 
septal wall, the area is measured (orange line).
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displacement of the surgical valve leaflets to oppose the surgi-
cal stent struts, resulting in a covered stent in the LVOT. Given 
this, a simulation of a more atrial deployment of the transcath-
eter heart valve will have no impact on the degree of LVOT 
encroachment. In valve in ring and valve in MAC, the mecha-
nism of neo-LVOT encroachment relates to displacement of 
the anterior leaflet of the mitral valve, and thus atrial offset of 
the transcatheter valve can help mitigate the risk of LVOT ob-
struction; therefore simulating the intended transcatheter heart 
valve to mimic the intended degree of atrial offset is important. 
When evaluating neo-LVOT obstruction risk in TMVR, it is 
important that the intended device be simulated. A conical 
structure is adequate when a traditional aortic transcatheter 
heart valve is being used in valve-in-valve and valve-in-MAC 
prior to valve insertion, which seems prudent in the early stages 
of clinical adoption of this technology. Unfortunately, there are 
little outcome data available validating this threshold currently, 
owing to limited clinical experience and exclusion of patients 
with narrow predicted neo-LVOT.
The image analysis for the prediction of the neo-LVOT ob-
struction is similar across the treatment of the various disease 
states, be it transcatheter valve in valve, valve in ring, MAC, 
or TMVR. The landing zone needs to be defined, and the size 
and type of the implanted device should be determined. There 
are subtle differences, though, in the mechanism and site of 
neo-LVOT obstruction in these different procedures. When 
inserting an aortic transcatheter heart valve within a failed 
bioprosthetic valve, the new transcatheter valve results in the 
Figure 12: Prediction of fluoroscopic angulation for coplanar deployment. A–C, Long-axis views of the mitral valve 
obtained aligned to the septal-lateral line (SL), trigone-to-trigone line (T T), and the commonly used compromise view. 
D–E, Annular views, with the blue line demonstrating how A–C views intersect the annulus. G–I, Images show how these 
views would appear on invasive angiograms based on three-dimensional CT data. J–K, Images demonstrate the sinusoi-
dal path the c-arm would follow as it rotates around the patient to always provide a tangential valvular view, with the 
x-axis describing the LAO-RAO tilt required and the y-axis describing the CRA-CAU tilt required. The yellow dots dem-
onstrate where each of the A–C views lie on this axis. LAO = left anterior oblique, RAO = right anterior oblique, CRA = 
cranial, CAU = caudal.
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7.7 (range, 1.9–38.9 mm) for the entire cohort and 18.0 mm 6 
7.9 and 16.9 mm 6 7.5 for patients with mitral regurgitation 
and degenerative mitral valve disease, respectively. The orthog-
onal LV access points offset in an anterolateral (n = 22, 40.7%) 
and anterior (n = 16, 29.6%) location, with the appropriate 
orthogonal LV access point showing significant interindividual 
variability and most commonly does not align with the true LV 
apex (61). By projecting an orthogonal line from the centroid 
of the mitral annulus and a mitral-apical line, the point of ac-
cess that would allow a true en face approach to the mitral an-
nulus can be generated either in relation to the true LV apex or 
in relation to adjacent landmarks such as the ribs and distance 
from the midline (Fig 13).
Additional Information
Further valve-specific measurements depend largely on the de-
vice being implanted. The reporting cardiac imager should be 
aware of the devices being considered for implantation at their 
local institute. Examples of such variations include the need 
to report the relationship of the left circumflex artery to the 
annulus in those being assessed for Cardioband insertion to 
minimize risk of coronary injury or the presence of posterior 
leaflet length and presence of leaflet tip calcification in those 
being considered for MitraClip (22,62).
In addition to valvular assessment, assessment of LV dimen-
sions and function, left atrial volume, and pulmonary artery 
pressures is of importance in the clinical decision making in pa-
tients with severe mitral regurgitation. In severe primary mitral 
regurgitation, the presence of LV ejection fraction of 60% or 
greater is an indication for surgery. In asymptomatic patients, 
the presence of an LV end systolic diameter of 40 mm or greater, 
left atrial dilatation ( 60 mL/m2), and increased systolic pul-
monary pressures (. 50 mmHg at rest or  60 mmHg during 
exercise) may be considered to indicate surgery when there is a 
high likelihood of durable valve repair (7). These variables can 
be assessed accurately and reproducibly with echocardiography 
(63). Similarly, right ventricular function has been shown to be 
prognostically important in patients with severe mitral regur-
gitation (64). Finally, in transcatheter mitral repair the mitral 
procedures. However, with TMVR, the best results will be ob-
tained by using dedicated software plug-ins that allow virtual 
generation of the shape and size of the actual valve to be used 
(Fig 11). Such an approach allows for a patient- and device-
specific neo-LVOT to be calculated, and thus a more accurate 
assessment of the risk of obstruction of the neo-LVOT.
Predicting Fluoroscopic Angulations
During any transcatheter cardiac intervention it is important 
for the proceduralist to deploy his or her device using fluoro-
scopic angulation that lies perpendicular to the mitral annulus, 
as obliquity can lead to an inaccurate appreciation of the true 
valve plane, and therefore, insertion of the device too far into 
the atrium or ventricle. For TMVR, this requires accurate imag-
ing of the mitral annular plane and the alignment of the septal-
lateral and intercommissural lines to ensure coaxial deployment. 
Similar to TAVR and left atrial appendage occlusion, CT has 
been shown to be helpful in generating patient-specific coplanar 
curves, allowing for coaxial deployment of the TMVR device 
(58–60) (Fig 12). In addition, by using centerline mapping, rele-
vant adjacent anatomy such as the location of the coronary sinus 
and left circumflex coronary artery can be defined and transmit-
ted to the hybrid, or to provide a roadmap during the procedure 
and define patient-specific risk.
Apex Localization and Septal Puncture
At present, the majority of devices under evaluation in feasibil-
ity studies have used transapical access (16). To help prevent 
device canting and resultant LVOT obstruction, inadequate 
sealing, and paravalvular regurgitation, the access point chosen 
should allow for a perpendicular delivery of the transcatheter 
mitral device to the mitral annulus. CT may play an important 
role in helping identify the appropriate access point in advance 
of the procedure. Early experiences have highlighted that there 
is significant variability regarding the appropriate access point 
across subjects and mechanisms of mitral regurgitation. Blanke 
and colleagues evaluated 54 subjects who were being evaluated 
for TMVR and noted that the mean distance between the “or-
thogonal” MV access point and the true apex was 17.6 mm 6 
Figure 13: Prediction of optimal point of access for an en face mitral annular approach. A, A true 
transapical approach (blue line) would result in a 17° off center angulation with respect to the mitral an-
nulus. B, The red line, representing a tangential projection from the centroid of the mitral annular plane, 
would enable a true direct approach and requires access to be achieved one rib space superior to the left 
ventricle apex.
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Table 2: Report Framework for Preprocedural CT
Anatomic Structure and Metric Detail
Annulus
 Qualitative Mitral annular calcification
 Extent of coverage according to segmental distribution (A1–A3 and P1–P3)
Mitroannular disjunction
 Quantitative* Area (+) 
Perimeter (+)
Intercommisural distance (+)
Septal-lateral distance (+)
Trigone-trigone distance (-)
Fluoroscopic angulation (+)
  Intercommisural view, compromise view, en face view
Leaflets
 Qualitative Leaflet thickness
Prolapse/flail segments
 Individually for A1–3 and P1–3
Leaflet tethering
Leaflet calcification
 Location (tip versus hinge)
 Extent
 Quantitative* Leaflet length (-)
Coaptation distance (-)
Tenting height/area (-)
Subvalvular apparatus
 Qualitative Number and insertion points
 Presence of bifid muscles or direct muscular insertions
 Quantitative* Interpapillary distance (-)
Chordae length (-)
Left ventricle
 Qualitative Global function
 Regional wall motion abnormalities
Myocardial scarring/calcification
 Quantitative*
Left ventricular end diastolic and end systolic internal diameter (+)
 The latter should be reported at the distal most aspect of the anticipated valve to be inserted
Long-axis length (-)
Neo-LVOT area (+)
Aortomitral angle (-)
Ejection fraction (-)
Apical location in relation to midline and intercostal space (-)
Cardiac
 Qualitative Incidental findings
 Left atrial appendage thrombus, interatrial septal aneurysm, ASD/PFO, relationship of the left  
  circumflex artery to coronary sinus
 Quantitative* Left atrial dimensions (-)
Right ventricular ejection fraction (-)
Extracardiac
 Qualitative Incidental findings
 Quantitative* Venous dimensions
 Venous stenosis is exceptionally rare in the absence of prior thombosis or prolonged/repeated  
   instrumentation and diameters are highly variable dependent on respiratory status thus  
should not be routinely performed (-)
* Quantitative metrics are marked as essential (+) when they are common to the majority of transcatheter mitral valve interventions and 
minor (-) when they are specific to select devices or for prognostic purposes rather than required for device selection.
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valve is accessed through transseptal puncture, and while most 
current TMVRs are inserted via a transapical approach, signifi-
cant advances are being made in transseptal approaches. Thus 
evaluation of the anatomy of the interatrial septum will become 
of increasing importance. The analysis of this is useful to antici-
pate the site of the puncture and minimize complications such 
as puncture of the aorta (65). An aneurysmal septum, a patent 
foramen ovale or atrial septal defects may pose challenges for 
TMV procedures (66). A suggested reporting checklist for pre-
procedural CT is provided in Table 2.
Conclusion
Rapid advancements in TMV procedures have driven an in-
creasing demand for noninvasive imaging to help assist in evalu-
ation and procedural planning. Echocardiography remains the 
imaging test of choice for the diagnosis of mitral valvular dis-
ease and the gradation of its severity. However, there is growing 
use of multidetector CT as a tool that can provide incremental 
information for annular sizing, landing zone characterization, 
risk stratification for LVOT obstruction, access point localiza-
tion, and fluoroscopic angles to guide the procedure.
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